These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4392560)

  • 21. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacology of dl-5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy) coumarin hydrochloride (CS-359), a new beta-adrenergic blocking agent.
    Oshima T; Kumakura S; Koike H; Nakayama K
    Jpn J Pharmacol; 1973 Aug; 23(4):497-513. PubMed ID: 4148384
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-arrhythmic ancd local anaesthetic activity of some beta-receptor blocking compounds.
    Hermansen K
    Br J Pharmacol; 1968 Sep; 34(1):200P. PubMed ID: 4300140
    [No Abstract]   [Full Text] [Related]  

  • 24. Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1969 Oct; 37(2):357-66. PubMed ID: 4390668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of beta adrenoceptor blocking agents on the membrane potential and spike generation in the smooth muscle of guinea-pig taenia coli.
    Davis WG
    Br J Pharmacol; 1970 Jan; 38(1):12-9. PubMed ID: 4391730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rate of onset of beta adrenergic blockade by the optical isomers of alprenolol.
    Buckner CK; Patil PN
    Eur J Pharmacol; 1971 May; 14(3):308-11. PubMed ID: 4405542
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
    Flórez J; Arconada JA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of pharmacological blockade of presynaptic and postsynaptic adrenergic structures on electrically induced arrhythmias of the guinea-pig atria.
    Grodzińska L
    Folia Biol (Krakow); 1969; 17(4):347-55. PubMed ID: 4392109
    [No Abstract]   [Full Text] [Related]  

  • 30. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer.
    Williams EM; Bagwell EE; Singh BN
    Cardiovasc Res; 1973 Mar; 7(2):226-40. PubMed ID: 4144352
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-adrenolytic, antiarrhythmic and local anaesthetic effects of phenylephrine.
    Reinhardt D; Wagner J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(3):245-61. PubMed ID: 4154414
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of prolonged treatment with oxyfedrine on intracellular potentials and on other features of cardiac function in rabbits and guinea-pigs.
    Polster P; Vaughan Williams EM
    Br J Pharmacol; 1973 Feb; 47(2):187-95. PubMed ID: 4146572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of adrenergic and some other cardioactive drugs on electric activity of the isolated frog atrium.
    Smejkal V; Rougier O; Garnier D
    Physiol Bohemoslov; 1970; 19(1):23-5. PubMed ID: 4394506
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of the adrenergic drugs on the electrical responses of the rabbit isolated heart atrium.
    Smejkal V; Mironneau J; Ojeda C; Gargouil YM
    Physiol Bohemoslov; 1970; 19(1):19-22. PubMed ID: 4394505
    [No Abstract]   [Full Text] [Related]  

  • 36. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta blocking drugs as anti-arrhythmic agents.
    Fitzgerald JD
    Int J Clin Pharmacol Biopharm; 1975 Apr; 11(3):235-44. PubMed ID: 238912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a new beta-adrenergic receptor blocking agent, alprenolol, andts optical isomers.
    Belliveau RE; Covino BG
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):341-9. PubMed ID: 4390664
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative studies on the question of differentiation of adrenergic beta-receptors].
    Mentz P; Bayer B; Wartner U; Förster W
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):23-9. PubMed ID: 4394699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.